BBWI Stock Forecast & Price Target

Bath & Body Works is supported by a defensible category position, strong brand awareness, and a vertically integrated supply chain that can enhance agility, scale, and margin control, while its roughly 7x ’26 EPS guide valuation suggests the market already discounts a lot of near-term uncertainty. The 1Q26 print was better than feared despite weak consumer sentiment, 2Q26 guidance was bracketing Street, and FY26 guidance was reaffirmed, while $250 million of targeted cost savings over two years, including $175 million expected in 2026, provides a meaningful earnings lever even as SG&A is forecast at 29.2% of sales. Although body care sales declined in the mid-teens and innovation remains a key execution risk, the company still benefits from healthy underlying industry demand in Body care, Soap & Sanitizers, and Home Fragrance, plus potential upside from easier comparisons, 2H26 disruptive launches, and growth in store upgrades, digital, international, and adjacent categories.

Bath & Body Works is facing a negative fundamental setup because its largest category, Body care, is underperforming mid-teens amid clear execution and product-relevance issues, with management admitting the assortment has lagged a benefit-driven, innovation-led market while the business remains too fragrance-centric and too dependent on promotions. Sales are also pressured by category and channel mix, including continued weakness in key periods, disruption from pulling back too aggressively in Everyday Luxuries, and international sales expected to fall in the near term due to Middle East disruptions, while gross margin was down 270bps and adjusted SG&A rose to 31.8% of sales, highlighting deleverage from lower demand, tariff and inflation pressure, and ongoing investment needs. Although the company still generates robust free cash flow and has $250M of cost savings identified over ’26 and ’27, the outlook stays cautious because the planned product refresh in 2H26 and expanded digital and Amazon initiatives have yet to prove they can reverse share losses, reduce reliance on discounts, or restore durable growth in a business where 77% of fiscal 2025 sales still came from stores and 4% from international markets.